Surgical Robots Industry Overview

The global surgical robots market size was estimated at USD 3.92 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030.

Shortage of physicians and surgeons across the globe and increasing adoption of automated instruments used for surgery are major factors driving market growth. Furthermore, growing prevalence of bone degenerative diseases and rising number of hip knee replacement surgeries due to increasing cases of arthritis osteoporosis are anticipated to drive growth. For instance, according to the Agency for Healthcare Research and Quality report, over 4,50,000 hip replacement surgeries are performed annually in the U.S.

Gather more insights about the market drivers, restrains and growth of the Surgical Robots Market

An increasing number of knee and hip replacement surgeries is one of the key factors anticipated to drive the adoption of surgical robots in healthcare industry. Some major disorders that affect joints are various types of arthritis, bone degenerative diseases, and osteoporosis. Rising prevalence of these conditions has led to an increase in the number of patients requiring knee and hip replacement surgeries.

As per the Australian Institute of Health and Welfare (AIHW) statistics, total knee replacement rate for osteoarthritis increased by about 38% from 2005-2006 to 2017-2018. According to the International Congress for Joint Reconstruction in March 2018, total number of primary hip replacement and knee replacement procedures is projected to reach 635,000 (171.0% increase) 1.28 million (189.0% increase), respectively, by 2030 and 1.23 million (330.0% growth) 2.60 million (382.0% growth) by 2060.

According to an article published by The Regents of the University of California in March 2017, total hip replacements are expected to increase by almost 200%, and total knee replacements performed in the U.S. are expected to increase by more than 600% by 2030 compared to 2005. This is driving the adoption of surgical robots, thereby aiding market growth. Furthermore, the postoperative functional outcome for patients is another significant growth driver. Robotic surgery supports surgeons in performing complicated procedures with greater flexibility, precision, and control over conventional surgeries.

In addition, benefits associated with these surgical procedures include low pain blood loss, shorter recovery period, lower risk of infection at the surgical site, and tiny or less noticeable scars, thereby aiding market growth. For instance, according to a study published by the Hip and Knee Society, the 90-day care cost for the patients who received a Mako total knee replacement was USD 2400 less than for the patients who received conventional knee replacement. The study also revealed a reduction of 33% in 90-day readmissions in patients receiving treatment using Mako.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global dental laboratory welders market sizewas valued at USD 172.8 million in 2023 and is expected to grow at a CAGR of 9.0% from 2024 to 2030.
• The global pharmaceutical inspection machines market size was valued at USD 862.0 million in 2023 and is projected to grow at a CAGR of 9.9% from 2024 to 2030.

Surgical Robots Market Segmentation

Grand View Research has segmented the global surgical robots market based on application, end-use, and region:

Surgical Robots Application Outlook (Revenue, USD Million, 2018 - 2030)

• Orthopedics
  • Knee
  • Hip
  • Spine
  • Others
• Neurology
• Urology
• Gynecology
• Others

Surgical Robots End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Inpatient
• Outpatient

Surgical Robots Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Companies profiled:

• Intuitive Surgical
• Medrobotics Corporation
• Medtronic
• Renishaw plc
• Smith and Nephew
• Stryker Corporation
• THINK Surgical, Inc.
• TransEnterix (Asensus Surgical, Inc.)
• Zimmer Biomet Holdings, Inc.

Key Surgical Robots Company Insights

• In January 2021, DePuy Synthes (Johnson Johnson) received FDA approval for its VELYS robotic system, improving its offerings with the ATTUNE TOTAL knee system. The entry of DePuy Synthes into the robotics surgical domain indicates a continuous and promising trend in the adoption of robotics for joint replacement surgeries
• In January 2022, Smith Nephew acquired Engage Surgical, which is involved in manufacturing cementless knee systems in the U.S. This acquisition improved its position in meniscal tear solutions and other knee arthroscopy devices
• In August 2023, Stryker launched a direct patient marketing campaign aimed at enhancing patient engagement and education. The campaign is designed to reach patients directly provide information about Stryker's innovative medical solutions, focusing on joint replacement procedures. By fostering better patient understanding awareness, Stryker aims to empower individuals to make informed decisions about their healthcare, ultimately improving their overall experience and outcomes

Order a free sample PDF of the Surgical Robots Market Intelligence Study, published by Grand View Research.